Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy

Journal of Clinical Pharmacy and Therapeutics

Volumn 39, Issue 3, 2014, Pages 240-247

  Saba, M ^a   Diep, J ^a   Saini, B ^a   Dhippayom, T ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NARESUAN UNIVERSITY   (Thailand)

Author keywords

community pharmacy; intervention; meta analysis; pharmacist; smoking cessation

Indexed keywords

NICOTINE PATCH; NICOTINE GUM;

ARTICLE; HUMAN; META ANALYSIS; NICOTINE REPLACEMENT THERAPY; PHARMACIST; PHARMACY; PROGRAM EFFECTIVENESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF CONCEPT; SMOKING; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; CLINICAL TRIAL (TOPIC); COUNSELING; ORGANIZATION AND MANAGEMENT; PROCEDURES;

CLINICAL TRIALS AS TOPIC; COMMUNITY PHARMACY SERVICES; COUNSELING; HUMANS; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS;

EID: 84899454745     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12131     Document Type: Article

References (42)

1. Chandler MA, Rennard SI,. Smoking cessation. Chest, 2010; 137: 428-435.
2. McEwen A, Hajek P, McRobbie H, West R,. Manual of smoking cessation. Oxford, UK: Blackwell Publishing: 2006, 23.
3. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T., Physician advice for smoking cessation. Cochrane Database Syst Rev, 2013;(5): CD000165.
4. Chouinard MC, Robichaud-Ekstrand S,. The effectiveness of a nursing inpatient smoking cessation program in individuals with cardiovascular disease. Nurs Res, 2005; 54: 243-254.
5. Rigotti NA, Clair C, Munafò MR, Stead LF,. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev, 2012;(5): CD001837.
6. Bala MM, Strzeszynski L, Topor-Madry R, Cahill K., Mass media interventions for smoking cessation in adults. Cochrane Database Syst Rev, 2013;(6): CD004704.
7. Asfar T, Ebbert JO, Klesges RC, Klosky JL,. Use of smoking reduction strategies among U.S. tobacco quitlines. Addict Behav, 2012; 37: 583-586.
8. Chen YF, Madan J, Welton N, et al,. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis. Health Technol Assess, 2012; 16: 1-205, iii-v.
9. World Health Organization. WHO Report on the Global Tobacco Epidemic-Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship, 2013. Available at: http://apps.who.int/iris/bitstream/10665/85380/1/9789241505871- eng.pdf (accessed 25 July 25 2013).
10. American Cancer Society. CDC: Adult Smoking Rates Remain Steady, 2012. Available at http://www.cancer.org/cancer/news/cdc-adult-smoking-rates-remain- steady (accessed 25 July 2013).
11. Chapman S, MacKenzie R,. There's nothing that succeeds like failure: discerning the woods from the trees in smoking cessation debates. Nicotine Tob Res, 2013; 15: 750-751.
12. Zwar N,. Smoking cessation-what works? Aust Fam Physician, 2008; 37: 10-14.
13. World Health Organization. The Role of the Pharmacist in the Health Care System. Available at: http://apps.who.int/medicinedocs/en/d/Jh2995e/1.6.2.html (accessed 19 July 2013).
14. Dent LA, Harris KJ, Noonan CW,. Tobacco interventions delivered by pharmacists: a summary and systematic review. Pharmacotherapy, 2007; 27: 1040-1051.
15. Black JH 3rd,. Evidence base and strategies for successful smoking cessation. J Vasc Surg, 2010; 51: 1529-1537.
16. Fiore MC, Jaén CR, Baker TB, et al,. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service, 2008.
17. Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T., Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews. Addiction, 2013; 108: 1711-1721.
18. Armour CL, Reddel HK, LeMay KS, et al,. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma, 2013; 50: 302-309.
19. Gordon J, Watson M, Avenell A,. Lightening the load? A systematic review of community pharmacy-based weight management interventions. Obes Rev, 2011; 12: 897-911.
20. Fuller JM, Wong KK, Krass I, Grunstein R, Saini B,. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ Couns, 2011; 83: 325-335.
21. Venkatesan R, Devi AS, Parasuraman S, Sriram S,. Role of community pharmacists in improving knowledge and glycemic control of type 2 diabetes. Perspect Clin Res, 2012; 3: 26-31.
22. Sinclair HK, Bond CM, Stead LF,. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev, 2004;(1): CD003698.
23. Blenkinsopp A, Anderson C, Armstrong M,. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med, 2003; 25: 144-153.
24. Roughead L, Semple S, Vitry A,. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990-2002. Adelaide, SA: Quality Use of Medicines and Pharmacy Research Centre, University of South Australia; 2003.
25. Sinclair HK, Silcock J, Bond CM, Lennox AS, Winfield AJ,. The cost-effectiveness of intensive pharmaceutical intervention in assisting people to stop smoking. Int J Pharm Pract, 1999; 7: 107-112.
26. Tran MT, Holdford DA, Kennedy DT, Small RE,. Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practice. Pharmacotherapy, 2002; 22: 1623-1631.
27. Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available at www.cochrane-handbook.org (accessed 23 July 2013).
28. Liberati A, Altman DG, Tetzlaff J, et al,. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. Br Med J, 2009; 21: b2700.
29. Bock BC, Hudmon KS, Christian J, Graham AL, Bock FR,. A tailored intervention to support pharmacy-based counseling for smoking cessation. Nicotine Tob Res, 2010; 12: 217-225.
30. Hodges L, Gilbert H, Sutton S,. Using computer-tailored smoking-cessation advice incommunity pharmacy: a feasibility study. Int J Pharm Pract, 2009; 17: 365-368.
31. Isacson D, Bingefors C, Ribohn M,. Quit smoking at the pharmacy-an evaluation of a smoking cessation programme in Sweden. J Soc Adm Pharm, 1998; 15: 164-173.
32. Maguire TA, McElnay JC, Drummond A,. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction, 2001; 96: 325-331.
33. Sinclair HK, Bond CM, Lennox AS, Winfield AJ,. Training pharmacists and pharmacy assistants in the stage of change model of smoking cessation: a randomised control trial in Scotland. Tob Control, 1998; 7: 253-261.
34. Stead LF, Lancaster T., Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev, 2012;(10): CD008286.
35. Stead LF, Lancaster T., Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev, 2012;(12): CD009670.
36. Cunningham JA, Kushnir V,. Could the use of biochemical validation of smoking abstinence introduce a confound into the interpretation of randomized controlled trials of tobacco cessation? Addiction, 2013; 108: 827-828.
37. West R, Hajek P, Stead L, Stapleton J,. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction, 2005; 100: 299-303.
38. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M,. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm, 2011; 68: 241-253.
39. Collins C, Limone BL, Scholle JM, Coleman CI,. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract, 2011; 92: 145-152.
40. Machado M, Nassor N, Bajcar JM, Guzzo GC, Einarson TR,. Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management. Ann Pharmacother, 2008; 42: 1195-1207.
41. Rice VH, Hartmann-Boyce J, Stead LF., Nursing interventions for smoking cessation. Cochrane Database Syst Rev, 2013;(8): CD001188. [Epub ahead of print].
42. McBane SE, Corelli RL, Albano CB, et al,. The role of academic pharmacy in tobacco cessation and control. Am J Pharm Educ, 2013; 77: 93.